Credent Connect N Care IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Aug 13 to Aug 17 2026
Price Band
₹179 - 189
Current GMP
₹359.1 (+90%)
Subscription
153.13 times
IPO Details
| IPO Date | 13 to 17 Aug, 2026 |
| Listing Date | Thu, Aug 20, 2026 |
| Face Value | ₹ 10 per share |
| Price Band | ₹179 to ₹189 |
| Issue Price | ₹189 per share |
| Lot Size | 600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 49,68,000 shares (agg. up to ₹ 94 Cr) |
| Reserved for Market Maker | 2,52,000 shares (agg. up to ₹ 5 Cr) Hem Finlease Pvt.Ltd. |
| Fresh Issue (Ex Market Maker) | 47,16,000 shares (agg. up to ₹ 89 Cr) |
| Net Offered to Public | 47,16,000 shares (agg. up to ₹ 89 Cr) |
| Share Holding Pre Issue | 1,32,54,900 shares |
| Share Holding Post Issue | 1,82,22,900 shares |
| NSE Symbol | CREDENT |
| ISIN | INE1KPX01025 |
IPO Date
13 to 17 Aug, 2026
Listing Date
Thu, Aug 20, 2026
Face Value
₹ 10 per share
Price Band
₹179 to ₹189
Issue Price
₹189 per share
Lot Size
600 Shares
Sale Type
Fresh capital only
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Total Issue Size
49,68,000 shares (agg. up to ₹ 94 Cr)
Reserved for Market Maker
2,52,000 shares (agg. up to ₹ 5 Cr) Hem Finlease Pvt.Ltd.
Fresh Issue (Ex Market Maker)
47,16,000 shares (agg. up to ₹ 89 Cr)
Net Offered to Public
47,16,000 shares (agg. up to ₹ 89 Cr)
Share Holding Pre Issue
1,32,54,900 shares
Share Holding Post Issue
1,82,22,900 shares
NSE Symbol
CREDENT
ISIN
INE1KPX01025
IPO Subscription Details
| Anchor | 1 |
| Market Maker | 1 |
| QIB (Ex Anchor) | 130.40 |
| NII*** | 216.97 |
| bNII (> ₹10L) | 255.58 |
| sNII (< ₹10L) | 139.76 |
| Individual Investors | 138.86 |
| Total ** | 153.13 |
Anchor
1
Market Maker
1
QIB (Ex Anchor)
130.40
NII***
216.97
bNII (> ₹10L)
255.58
sNII (< ₹10L)
139.76
Individual Investors
138.86
Total **
153.13
Day Wise Sub
| Day | QIB (Ex Anchor) | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Aug 1 3 (Day 1) | 1.00 | 1.59 | 1.44 | 1.90 | 3.11 | 2.18 |
| Aug 1 4 (Day 2) | 6.45 | 9.73 | 8.10 | 12.99 | 16.43 | 12.14 |
| Aug 1 7 (Day 3) | 130.40 | 216.97 | 255.58 | 139.76 | 138.86 | 153.13 |
DayAug 1
3 (Day 1)
QIB (Ex Anchor)1.00
NII*1.59
NII (> ₹10L)1.44
NII (< ₹10L)1.90
Individual Investors3.11
Total2.18
DayAug 1
4 (Day 2)
QIB (Ex Anchor)6.45
NII*9.73
NII (> ₹10L)8.10
NII (< ₹10L)12.99
Individual Investors16.43
Total12.14
DayAug 1
7 (Day 3)
QIB (Ex Anchor)130.40
NII*216.97
NII (> ₹10L)255.58
NII (< ₹10L)139.76
Individual Investors138.86
Total153.13
Day Wise GMP
| GMP Date | IPO Price | GMP | Est. Listing Price |
|---|---|---|---|
| 20-08-2026 | 189 | 92 (48.68%) | 281 |
| 19-08-2026 | 189 | 92 (48.68%) | 281 |
| 18-08-2026 | 189 | 63 (33.33%) | 252 |
| 17-08-2026 | 189 | 45 (23.81%) | 234 |
| 16-08-2026 | 189 | 55 (29.10%) | 244 |
| 15-08-2026 | 189 | 55 (29.10%) | 244 |
| 14-08-2026 | 189 | 65 (34.39%) | 254 |
| 13-08-2026 | 189 | 75 (39.68%) | 264 |
| 12-08-2026 | 189 | 50 (26.46%) | 239 |
| 11-08-2026 | 189 | 35 (18.52%) | 224 |
| 10-08-2026 | 189 | 0 (0%) | 189 |
GMP Date20-08-2026
IPO Price189
GMP92 (48.68%)
Est. Listing Price281
GMP Date19-08-2026
IPO Price189
GMP92 (48.68%)
Est. Listing Price281
GMP Date18-08-2026
IPO Price189
GMP63 (33.33%)
Est. Listing Price252
GMP Date17-08-2026
IPO Price189
GMP45 (23.81%)
Est. Listing Price234
GMP Date16-08-2026
IPO Price189
GMP55 (29.10%)
Est. Listing Price244
GMP Date15-08-2026
IPO Price189
GMP55 (29.10%)
Est. Listing Price244
GMP Date14-08-2026
IPO Price189
GMP65 (34.39%)
Est. Listing Price254
GMP Date13-08-2026
IPO Price189
GMP75 (39.68%)
Est. Listing Price264
GMP Date12-08-2026
IPO Price189
GMP50 (26.46%)
Est. Listing Price239
GMP Date11-08-2026
IPO Price189
GMP35 (18.52%)
Est. Listing Price224
GMP Date10-08-2026
IPO Price189
GMP0 (0%)
Est. Listing Price189
IPO Important Dates
| IPO Open | Thu, Aug 13, 2026 |
| IPO Close | Mon, Aug 17, 2026 |
| Allotment | Tue, Aug 18, 2026 |
| Refund | Wed, Aug 19, 2026 |
| Credit of Shares | Wed, Aug 19, 2026 |
| Listing | Thu, Aug 20, 2026 |
IPO Open
Thu, Aug 13, 2026
IPO Close
Mon, Aug 17, 2026
Allotment
Tue, Aug 18, 2026
Refund
Wed, Aug 19, 2026
Credit of Shares
Wed, Aug 19, 2026
Listing
Thu, Aug 20, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 1,200 | ₹2,26,800 |
| Individual investors (IND) (Max) | 2 | 1,200 | ₹2,26,800 |
| S-HNI (Min) | 3 | 1,800 | ₹3,40,200 |
| S-HNI (Max) | 8 | 4,800 | ₹9,07,200 |
| B-HNI (Min) | 9 | 5,400 | ₹10,20,600 |
ApplicationIndividual investors (IND) (Min)
Lots2
Shares1,200
Amount₹2,26,800
ApplicationIndividual investors (IND) (Max)
Lots2
Shares1,200
Amount₹2,26,800
ApplicationS-HNI (Min)
Lots3
Shares1,800
Amount₹3,40,200
ApplicationS-HNI (Max)
Lots8
Shares4,800
Amount₹9,07,200
ApplicationB-HNI (Min)
Lots9
Shares5,400
Amount₹10,20,600
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Assets | 29.50 | 26.41 |
| Total Income | 78.23 | 76.02 |
| Profit After Tax | 2.25 | 2.66 |
| EBITDA | 4.99 | 4.30 |
| NET Worth | 15.90 | 13.66 |
| Reserves and Surplus | 15.70 | 13.46 |
| Total Borrowing | 7.42 | 6.85 |
Period EndedAssets
31 Mar 202529.50
31 Mar 202426.41
Period EndedTotal Income
31 Mar 202578.23
31 Mar 202476.02
Period EndedProfit After Tax
31 Mar 20252.25
31 Mar 20242.66
Period EndedEBITDA
31 Mar 20254.99
31 Mar 20244.30
Period EndedNET Worth
31 Mar 202515.90
31 Mar 202413.66
Period EndedReserves and Surplus
31 Mar 202515.70
31 Mar 202413.46
Period EndedTotal Borrowing
31 Mar 20257.42
31 Mar 20246.85
Key Performance Indicator
| ROE | 61.81% |
| ROCE | 40.00% |
| Debt/Equity | 0.50 |
| RoNW | 42.13% |
| PAT Margin | 8.61% |
| EBITDA Margin | 13.29% |
| NAV | 33.12 |
| Price to Book Value | 5.71 |
ROE
61.81%
ROCE
40.00%
Debt/Equity
0.50
RoNW
42.13%
PAT Margin
8.61%
EBITDA Margin
13.29%
NAV
33.12
Price to Book Value
5.71
IPO Reservation
| QIB | 23,52,000 |
| − Anchor Investor | 14,04,000 |
| − QIB (Ex. Anchor) | 9,48,000 |
| NII (HNI) | 7,08,000 |
| − bNII > ₹10L | 4,72,000 |
| − sNII < ₹10L | 2,36,000 |
| Retail | 16,56,000 |
| Market Maker | 2,52,000 |
| Total | 49,68,000 |
QIB
23,52,000
− Anchor Investor
14,04,000
− QIB (Ex. Anchor)
9,48,000
NII (HNI)
7,08,000
− bNII > ₹10L
4,72,000
− sNII < ₹10L
2,36,000
Retail
16,56,000
Market Maker
2,52,000
Total
49,68,000
Information about company
Incorporated in June 2015 as Credent Cold Chain Logistics Private Limited. Credent Connect N Care Limited is an integrated healthcare services and logistics provider offering technology-enabled operational, workforce and supply chain solutions to healthcare institutions across India. The company primarily operates on a B2B model, serving diagnostic laboratories, IVD companies, pharmaceutical companies, hospitals, clinics and other healthcare enterprises
The company offers a comprehensive portfolio of healthcare services, including home sample collection through trained phlebotomists, stationed phlebotomy and laboratory manpower services, diagnostic and paramedical services, healthcare logistics, operations and supply chain management, corporate wellness programs and technology-enabled courier aggregation through its C3 Post platform. Its logistics solutions support the movement of diagnostic samples, medical supplies, reagents and other healthcare consignments through temperature-controlled and time-sensitive transportation, including cold-chain logistics.
Credent Connect N Care operates through a pan-India network, supported by warehouses, branch offices, commercial vehicles, field personnel and technology platforms for tracking, workforce management and operational coordination. The company also operates its corporate wellness vertical under the “C3 Wellness” brand, providing health camps, vaccination programs, preventive health check-ups, radiology and diagnostic services, and on-ground healthcare manpower.
As of March 31, 2026, the Company had a workforce of 6,338 employees, comprising 4,052 payroll and 2,286 contractual employees across various functions.
The company has expanded its capabilities through strategic acquisitions, including Credent Healthcare Private Limited, Credent Team Private Limited and Alltrak Technologies Private Limited. Its operations are supported by ISO 9001:2015 and ISO 15189:2022 certifications, while its experienced promoter-led management team brings expertise in healthcare logistics and operations.
Key Strengths
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
#: Issue Objects
1: Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement
2: Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery
3: To meet Working Capital Requirements
4: Repayment and/or repayment, in full or part, of borrowing availed by the Company
5: General corporate purposes
: Total
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App